ACER
Price:
$0.9
Market Cap:
$22.02M
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID...[Read more]
Industry
Biotechnology
IPO Date
2004-04-14
Stock Exchange
NASDAQ
Ticker
ACER
According to Acer Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.47. This represents a change of -12.65% compared to the average of -0.54 of the last 4 quarters.
The mean historical PE Ratio of Acer Therapeutics Inc. over the last ten years is -2.33. The current -0.47 PE Ratio has changed 1.91% with respect to the historical average. Over the past ten years (40 quarters), ACER's PE Ratio was at its highest in in the March 2023 quarter at -0.15. The PE Ratio was at its lowest in in the September 2018 quarter at -17.41.
Average
-2.33
Median
-1.47
Minimum
-8.09
Maximum
-0.82
Discovering the peaks and valleys of Acer Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 341.15%
Maximum Annual PE Ratio = -0.82
Minimum Annual Increase = -82.68%
Minimum Annual PE Ratio = -8.09
Year | PE Ratio | Change |
---|---|---|
2022 | -1.42 | -35.69% |
2021 | -2.21 | 73.57% |
2020 | -1.27 | -9.19% |
2019 | -1.40 | -82.68% |
2018 | -8.09 | 124.38% |
2017 | -3.60 | 341.15% |
2016 | -0.82 | -39.78% |
2015 | -1.36 | -10.32% |
2014 | -1.51 | -8.65% |
2013 | -1.66 | 97.27% |
The current PE Ratio of Acer Therapeutics Inc. (ACER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.63
5-year avg
-2.88
10-year avg
-2.33
Acer Therapeutics Inc.’s PE Ratio is less than NRx Pharmaceuticals, Inc. (0), greater than Pasithea Therapeutics Corp. (-0.69), less than SAB Biotherapeutics, Inc. (-0.27), greater than Lexaria Bioscience Corp. (-0.65), greater than Navidea Biopharmaceuticals, Inc. (-8.94), less than ZyVersa Therapeutics, Inc. (0.03), less than Biodexa Pharmaceuticals Plc (-0.10), less than Oncorus, Inc. (-0.05), less than Kiromic BioPharma, Inc. (-0.04), less than YS Biopharma Co., Ltd. (-0.14), greater than BiomX Inc. (-2.20), less than Avenue Therapeutics, Inc. (-0.44), less than Hoth Therapeutics, Inc. (-0.31), greater than Revelation Biosciences, Inc. (-0.98), less than NeuroBo Pharmaceuticals, Inc. (-0.09), greater than Virax Biolabs Group Limited (-0.73), greater than null (-1.34),
Company | PE Ratio | Market cap |
---|---|---|
0 | $17.73M | |
-0.69 | $4.37M | |
-0.27 | $26.21M | |
-0.65 | $49.49M | |
-8.94 | $100.08K | |
0.03 | $2.70M | |
-0.10 | $105.64K | |
-0.05 | $3.14M | |
-0.04 | $3.14M | |
-0.14 | $192.09M | |
-2.20 | $21.30M | |
-0.44 | $4.05M | |
-0.31 | $7.32M | |
-0.98 | $1.43M | |
-0.09 | $29.70M | |
-0.73 | $15.24M | |
-1.34 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acer Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acer Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Acer Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Acer Therapeutics Inc. (ACER)?
What is the highest PE Ratio for Acer Therapeutics Inc. (ACER)?
What is the 3-year average PE Ratio for Acer Therapeutics Inc. (ACER)?
What is the 5-year average PE Ratio for Acer Therapeutics Inc. (ACER)?
How does the current PE Ratio for Acer Therapeutics Inc. (ACER) compare to its historical average?